These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10379972)

  • 41. Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment.
    Chevalier S; Farsijani S
    Appl Physiol Nutr Metab; 2014 Jun; 39(6):643-53. PubMed ID: 24869969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Segidrin: a new-type antineoplastic agent].
    Filov VA
    Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
    [No Abstract]   [Full Text] [Related]  

  • 43. Newly identified factors that alter host metabolism in cancer cachexia.
    Tisdale MJ
    Trends Pharmacol Sci; 1990 Dec; 11(12):473-5. PubMed ID: 2080549
    [No Abstract]   [Full Text] [Related]  

  • 44. Thalidomide: dual benefits in palliative medicine and oncology.
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(5):347-51. PubMed ID: 11565189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The molecular bases of the cachexia associated with cancer].
    Argilés JM; López Soriano FJ
    Med Clin (Barc); 1990 Jan; 94(1):18-20. PubMed ID: 2186226
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of cysteine and glutathione in HIV infection and cancer cachexia: therapeutic intervention with N-acetylcysteine.
    Dröge W; Gross A; Hack V; Kinscherf R; Schykowski M; Bockstette M; Mihm S; Galter D
    Adv Pharmacol; 1997; 38():581-600. PubMed ID: 8895825
    [No Abstract]   [Full Text] [Related]  

  • 47. Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference.
    Kung T; Springer J; Doehner W; Anker SD; von Haehling S
    Expert Opin Investig Drugs; 2010 Apr; 19(4):579-85. PubMed ID: 20367196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydrazine sulfate used in cancer patients.
    Smigel K
    J Natl Cancer Inst; 1990 Feb; 82(4):254. PubMed ID: 2405169
    [No Abstract]   [Full Text] [Related]  

  • 49. YC-1 rescues cancer cachexia by affecting lipolysis and adipogenesis.
    Chung TH; Yen-Ping Kuo M; Chen JK; Huang DM
    Int J Cancer; 2011 Nov; 129(9):2274-83. PubMed ID: 21557215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokines and cancer cachexia.
    Beutler B
    Hosp Pract (Off Ed); 1993 Apr; 28(4):45-52. PubMed ID: 8463366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malignancy. Cancer cachexia.
    Calman KC
    Br J Hosp Med; 1982 Jan; 27(1):28-9, 33-4. PubMed ID: 6800431
    [No Abstract]   [Full Text] [Related]  

  • 52. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
    Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
    Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer-related anorexia-cachexia syndrome.
    Walz DA
    Clin J Oncol Nurs; 2010 Jun; 14(3):283-7. PubMed ID: 20529791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical management of anorexia and cachexia in patients with advanced cancer.
    Bruera E
    Oncology; 1992; 49 Suppl 2():35-42. PubMed ID: 1461626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Proper nutrition is important for cancer patients].
    Paur I; Slåttholm MA; Ryel AL; Smeland S
    Tidsskr Nor Laegeforen; 2018 Jun; 138(11):. PubMed ID: 29947205
    [No Abstract]   [Full Text] [Related]  

  • 56. Protein calorie malnutrition and cancer therapy.
    Parnes HL; Aisner J
    Drug Saf; 1992; 7(6):404-16. PubMed ID: 1418697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer-associated cachexia.
    Nat Rev Dis Primers; 2018 Jan; 4():17106. PubMed ID: 29345250
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
    Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
    Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydrazine sulfate: a current perspective.
    Gold J
    Nutr Cancer; 1987; 9(2-3):59-66. PubMed ID: 3104888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Favorable responses to tocilizumab in two patients with cancer-related cachexia.
    Hirata H; Tetsumoto S; Kijima T; Kida H; Kumagai T; Takahashi R; Otani Y; Inoue K; Kuhara H; Shimada K; Nagatomo I; Takeda Y; Goya S; Yoshizaki K; Kawase I; Tachibana I; Kishimoto T; Kumanogoh A
    J Pain Symptom Manage; 2013 Aug; 46(2):e9-e13. PubMed ID: 23602326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.